PPT Slide
Leishmania bearing auxotrophic gene knockouts
can be safe and induce protective immunity
The results of the first trial of a vaccine against
visceral leishmaniasis in humans
The Lancet by Khalil et al. (356 [9241] 4 November 2000).
Leishmaniasis: Current status of vaccine development,
Clinical Microbiology Reviews, Volume 14, Issue
Management of cutaneous leishmaniasis, Current Opinion in
Infectious Diseases, Volume 14, Issue
2, 2001, Pages 151-154 Hepburn N.C.